The Plasmodium falciparum chromosome 2 project was funded by the National Institute of Allergy and Infectious Diseases (NIAID ).
Since shingles is very common in HIV-infected children, the NIAID and NICHD also launched a clinical study to determine whether Varivax can prevent shingles in HIV-infected children who have had chickenpox.
Parents may consider enrolling their EG diagnosed child or adolescent in a clinical trial sponsored by the National Institute of Allergy and Infectious Diseases (NIAID).
Dr. Mark Dybul, of the National Institute of Allergy and Infectious Diseases (NIAID) and the study author, noted that this approach together with high patient adherence could be a powerful and cost-effective tool in HIV treatment.